Cardiovascular drugs are instrumental in the comprehensive management of various heart and vascular conditions. These pharmaceutical interventions are formulated to intricately modulate the cardiovascular system, addressing issues like blood pressure regulation, cholesterol reduction, and the treatment of diverse cardiovascular disorders. Among the array of cardiovascular drugs, calcium channel blockers stand out, effectively relaxing blood vessels and reducing the heart's workload. Another essential class is diuretics, which assist in flushing excess salt and water from the body, ultimately lowering blood pressure. Vasodilators, designed to widen blood vessels, are also crucial components in the pharmacological approach to cardiovascular health. The dynamic field of cardiovascular medicine continually explores innovative drug therapies to enhance patient outcomes, emphasizing the importance of tailored treatment plans and close monitoring by healthcare professionals. Patients receiving cardiovascular drugs should actively engage in their prescribed regimen, prioritize regular medical evaluations, and adopt lifestyle modifications to optimize overall cardiovascular well-being.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : Improving Screening and Treatment of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Cycle Quality Improvement Project
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom